trial · primary record
Placebo
Psoriatic Arthritis (PsA)
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 444 |
| Primary completion | 2029-01 |
| Primary endpoint | Percentage of Participants With an American College of Rheumatology 20% (ACR20) Response at Week 24 |
| Registry ID | NCT03671148 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:50.964Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03671148
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Placebo · compound